3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Neuroblastoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Chronic-Phase
5
Burkitt Lymphoma
5
Myelodysplastic Syndromes
4
Lymphoma
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Graft vs Host Disease
3
Dendritic Cell Sarcoma, Interdigitating
3
Blast Crisis
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Sarcoma
2
Recurrence
2
Primary Myelofibrosis
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Ovarian Neoplasms
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Interventions
Levetiracetam
6
perampanel
2
Tranexamic Acid
2
Standard of Care
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Temozolomide
1
Spironolactone
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Magnesium Sulfate
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seizures
×
Methylprednisolone
×
CNS
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled